Robin Hull

2.1k total citations · 1 hit paper
20 papers, 1.6k citations indexed

About

Robin Hull is a scholar working on Virology, Epidemiology and Immunology. According to data from OpenAlex, Robin Hull has authored 20 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Virology, 10 papers in Epidemiology and 9 papers in Immunology. Recurrent topics in Robin Hull's work include HIV Research and Treatment (13 papers), Immune Cell Function and Interaction (7 papers) and Virology and Viral Diseases (4 papers). Robin Hull is often cited by papers focused on HIV Research and Treatment (13 papers), Immune Cell Function and Interaction (7 papers) and Virology and Viral Diseases (4 papers). Robin Hull collaborates with scholars based in United Kingdom, United States and Canada. Robin Hull's co-authors include David Smith, David B. Morton, Y. Rabémampianina, J Vidal, Rudolf Pfister, Philip D. Minor, Javier Martín, Glynis Dunn, Neil Almond and Richard Stebbings and has published in prestigious journals such as Journal of Virology, Virology and Journal of General Virology.

In The Last Decade

Robin Hull

20 papers receiving 1.5k citations

Hit Papers

A good practice guide to the administration of substances... 2001 2026 2009 2017 2001 250 500 750 1000

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robin Hull United Kingdom 14 328 314 251 236 228 20 1.6k
Stephen S. Hwang United States 17 314 1.0× 376 1.2× 812 3.2× 531 2.3× 174 0.8× 38 1.8k
Janis Lazdins Switzerland 24 491 1.5× 611 1.9× 216 0.9× 404 1.7× 978 4.3× 41 2.6k
John E. Wolf United States 31 368 1.1× 161 0.5× 199 0.8× 238 1.0× 929 4.1× 79 2.8k
Kenji Baba Japan 21 423 1.3× 152 0.5× 85 0.3× 120 0.5× 163 0.7× 162 1.6k
Carmen Punzón Spain 22 548 1.7× 557 1.8× 109 0.4× 85 0.4× 261 1.1× 36 1.6k
J. T. Fleming United States 16 712 2.2× 374 1.2× 470 1.9× 191 0.8× 154 0.7× 26 2.3k
Glenn H. Cantor United States 24 642 2.0× 239 0.8× 40 0.2× 188 0.8× 221 1.0× 49 1.8k
Mahavir Singh United States 27 1.0k 3.2× 251 0.8× 82 0.3× 163 0.7× 369 1.6× 96 2.3k
Zhongxia Li China 22 394 1.2× 188 0.6× 35 0.1× 182 0.8× 155 0.7× 112 1.5k
Carlos A. Sorgi Brazil 25 549 1.7× 340 1.1× 83 0.3× 211 0.9× 245 1.1× 91 1.8k

Countries citing papers authored by Robin Hull

Since Specialization
Citations

This map shows the geographic impact of Robin Hull's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robin Hull with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robin Hull more than expected).

Fields of papers citing papers by Robin Hull

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robin Hull. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robin Hull. The network helps show where Robin Hull may publish in the future.

Co-authorship network of co-authors of Robin Hull

This figure shows the co-authorship network connecting the top 25 collaborators of Robin Hull. A scholar is included among the top collaborators of Robin Hull based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robin Hull. Robin Hull is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Page, Mark, Richard Stebbings, Neil Berry, et al.. (2012). Heterologous protection elicited by candidate monomeric recombinant HIV-1 gp120 vaccine in the absence of cross neutralising antibodies in a macaque model. Retrovirology. 9(1). 56–56. 4 indexed citations
2.
Berry, Neil, Richard Stebbings, Claire Ham, et al.. (2008). Resistance to superinfection by a vigorously replicating, uncloned stock of simian immunodeficiency virus (SIVmac251) stimulates replication of a live attenuated virus vaccine (SIVmacC8). Journal of General Virology. 89(9). 2240–2251. 29 indexed citations
3.
Ferguson, David, A.M. Wade-Evans, P. Silvera, et al.. (2007). Preparation and characterization of new challenge stocks of SIVmac32H J5 following rapid serial passage of virus in vivo. Journal of Medical Primatology. 36(3). 131–142. 6 indexed citations
6.
Stebbings, Richard, Neil Berry, Herman Waldmann, et al.. (2005). CD8 + Lymphocytes Do Not Mediate Protection against Acute Superinfection 20 Days after Vaccination with a Live Attenuated Simian Immunodeficiency Virus. Journal of Virology. 79(19). 12264–12272. 29 indexed citations
7.
Stebbings, Richard, Neil Berry, Jim Stott, et al.. (2004). Vaccination with live attenuated simian immunodeficiency virus for 21 days protects against superinfection. Virology. 330(1). 249–260. 27 indexed citations
8.
Stebbings, Richard, Neil Almond, Neil Berry, et al.. (2002). Mechanisms of Protection Induced by Attenuated Simian Immunodeficiency Virus. Virology. 296(2). 338–353. 45 indexed citations
9.
Wade-Evans, A.M., Jim Stott, Tomáš Hanke, et al.. (2001). Specific Proliferative T Cell Responses and Antibodies Elicited by Vaccination with Simian Immunodeficiency Virus Nef Do Not Confer Protection against Virus Challenge. AIDS Research and Human Retroviruses. 17(16). 1517–1526. 6 indexed citations
10.
Silvera, Peter, et al.. (2001). Mechanisms of protection induced by live attenuated simian immunodeficiency virus. Journal of Medical Primatology. 30(1). 1–13. 15 indexed citations
11.
Hull, Robin, David B. Morton, Rudolf Pfister, et al.. (2001). A good practice guide to the administration of substances and removal of blood, including routes and volumes. Journal of Applied Toxicology. 21(1). 15–23. 1091 indexed citations breakdown →
12.
Silvera, Peter, Robin Hull, R. W. Cook, et al.. (2001). In situ hybridization and immunolabelling study of the early replication of simian immunodeficiency virus (SIVmacJ5) in vivo. Journal of General Virology. 82(9). 2225–2234. 22 indexed citations
13.
Ni, Haolin, Kate D. Ryman, Heiman Wang, et al.. (2000). Interaction of Yellow Fever Virus French Neurotropic Vaccine Strain with Monkey Brain: Characterization of Monkey Brain Membrane Receptor Escape Variants. Journal of Virology. 74(6). 2903–2906. 27 indexed citations
14.
Martín, Javier, et al.. (2000). Evolution of the Sabin Strain of Type 3 Poliovirus in an Immunodeficient Patient during the Entire 637-Day Period of Virus Excretion. Journal of Virology. 74(7). 3001–3010. 127 indexed citations
15.
Afzal, Muhammad, et al.. (1999). Evaluation of the Neurovirulence Test for Mumps Vaccines. Biologicals. 27(1). 43–49. 22 indexed citations
16.
Stebbings, Richard, Jim Stott, Neil Almond, et al.. (1998). Mechanisms of Protection Induced by Attenuated Simian Immunodeficiency Virus II. Lymphocyte Depletion Does Not Abrogate Protection. AIDS Research and Human Retroviruses. 14(13). 1187–1198. 31 indexed citations
18.
Almond, Neil, T. Corcoran, Robin Hull, et al.. (1997). Mechanisms of protection induced by attenuated simian immunodeficiency virus. IV. Protection against challenge with virus grown in autologous simian cells. Journal of Medical Primatology. 26(1-2). 34–43. 7 indexed citations
19.
Hull, Robin. (1972). Cyclical transmission of a West African strain of Trypanosoma vivax in rabbits. Transactions of the Royal Society of Tropical Medicine and Hygiene. 66(2). 334–335. 4 indexed citations
20.
Hull, Robin. (1971). Laboratory studies on a South American strain of Trypanosoma vivax. Transactions of the Royal Society of Tropical Medicine and Hygiene. 65(2). 257–258. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026